JPRN-UMIN000014139已完成未知
Comparison of efficacy and safety of sitagliptin or ipragliflozin in type 2 diabetic patients with insulin therapy - Administration of sitagliptin or ipragliflozin in type 2 diabetic patients with insulin therapy
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients whose BMI is less than 18 Patients with moderale renal disfunction Patients with sever liver disfunction Patients who have experienced severe diabetic ketosis, diabetic coma, or past history of pre-coma prior to 3 months Patients with sever infection, operation, trauma, and urine and genital infection Female patients who have pregnancy or possibilty of pregnancy, or are under lactation Patients who are considered to be not eligible to the study by the doctor
研究者
相似试验
已完成
2 期
Sitagliptin and Pioglitazon effects in the treatment of diabetesIRCT2015061619554N4Vice chancellor for research; Zanjan University of Medical Sciences160
已完成
不适用
Efficacy and Safety comparison of Sitagliptin and Glimepiride in elderly Japanese patients with type 2 diabetestype 2 diabetesJPRN-UMIN000004047Japan Association for Diabetes Education and Care900
尚未招募
4 期
A clinical study to understand the combined effects ofSitagliptin & metformin, in comparison to Glimepiride & metformin treatment in type 2 diabetes patientsCTRI/2024/04/065877Dr Keerthi Rajan M
招募中
2 期
?Evaluation the effects of Sitagliptin administration in patients with COVID-19Pneumonia of COVID-19.COVID-19, virus identifiedU07.1IRCT20200420047147N1Shahid Beheshti University of Medical Sciences84
已完成
不适用
Efficacy and safety of sitagliptin in patients with type 2 diabetes: a multicentre observational studyDiabetes mellitusJPRN-UMIN000005994Association for future management of diabetes500